TotalMarketCap

Sera Prognostics

SERANasdaq United StatesHealth CareMedical Specialities

Market cap

$82.522 M

$2.08 +2.98%

Close of 6 Nov 2026

As of 6 Nov 2026, Sera Prognostics (SERA) has a market capitalization of $82.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$81.0K

#3573 by revenue

Earnings

-$31.9M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →
  1. #36Burning Rock BiotechBNR$139.2M
  2. #37Kewaunee ScientificKEQU$98.0M
  3. #38Sera PrognosticsSERA$82.5M
  4. #39Accendra HealthACH$20.8M
  5. #40MDxHealthMDXH$14.8M

What if Sera Prognostics were worth as much as…

Open the what-if tool →

Gold $28.2T

$710,007.24

Per share 342,172× higher

Bitcoin $1.53T

$38,417.26

Per share 18,514× higher

Apple $5.02T

$126,120.26

Per share 60,781× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Sera Prognostics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.